Document is current
Any future updates will be listed below
-
Authors
Chase, Dana M. https://orcid.org/0000-0002-1073-8688
Hanna, Maya
Lim, Jonathan T.
Boyle, Tirza Areli Calderón
Guinter, Mark
Richey, Madeline
Patel, Khilna
Schilder, Jeanne M.
Hurteau, Jean A.
Golembesky, Amanda K.
-
Funding
Funding for this research was provided by:
GSK
- License Information
-
More Information
Article History
Received: 19 September 2024
Accepted: 15 November 2024
First Online: 7 January 2025
Declarations
:
: Dana M. Chase reports consultant fees from AstraZeneca and GSK and honoraria from AstraZeneca, GSK, ImmunoGen, and Seagen/Genmab. Maya Hanna, Jonathan T. Lim, Tirza Areli Calderón Boyle, Jeanne M. Schilder, Jean A. Hurteau, and Amanda K. Golembesky are employees of GSK and may hold stocks/shares in GSK. Mark Guinter, Madeline Richey, and Khilna Patel are employees of Flatiron Health, Inc., which is an independent member of the Roche Group, and report stock ownership in the Roche Group.
: Permission for authors to access/use the database was provided by Flatiron Health, Inc. This study complied with all applicable patient privacy laws. There was no direct patient contact or primary collection of individual human subject data. The data were deidentified and subject to obligations to prevent reidentification and protect patient confidentiality. Therefore, informed consent and ethics committee or institutional review board approval were not required.
